Effects of fibrinogen and α2-macroglobulin and their apheretic elimination on general blood rheology and rheological characteristics of red blood cell aggregates

Therapeutic Apheresis and Dialysis

Volumn 12, Issue 5, 2008, Pages 360-367

  Kirschkamp, Thomas ^a   Schmid Schönbein, Holger ^b   Weinberger, Andreas ^a   Smeets, Ralf ^b  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^b RWTH AACHEN UNIVERSITY   (Germany)

Author keywords

Age related maculopathy; Alpha 2 macroglobulin; Extracorporeal elimination; Rheology; Therapeutic apheresis

Indexed keywords

ALPHA 2 MACROGLOBULIN; FIBRINOGEN;

APHERESIS; ARTICLE; BLOOD RHEOLOGY; CONTROLLED STUDY; DIABETES MELLITUS; ERYTHROCYTE; ERYTHROCYTE AGGREGATION; ERYTHROCYTE DEFORMABILITY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MICROSCOPY; PRIORITY JOURNAL; RETINA MACULA AGE RELATED DEGENERATION; ANIMAL; BLOOD FLOW VELOCITY; BLOOD VISCOSITY; CAPILLARY RESISTANCE; CELL CULTURE; COMPARATIVE STUDY; IN VITRO STUDY; METABOLISM; MICROCIRCULATION; PHYSIOLOGY; RAT; SENSITIVITY AND SPECIFICITY;

ALPHA-MACROGLOBULINS; ANIMALS; BLOOD COMPONENT REMOVAL; BLOOD FLOW VELOCITY; BLOOD VISCOSITY; CAPILLARY RESISTANCE; CELLS, CULTURED; ERYTHROCYTE AGGREGATION; FIBRINOGEN; HEMORHEOLOGY; HUMANS; MICROCIRCULATION; RATS; SENSITIVITY AND SPECIFICITY;

EID: 53849089949     PISSN: 17449979     EISSN: 17449987     Source Type: Journal    
DOI: 10.1111/j.1744-9987.2008.00610.x     Document Type: Article

References (31)

1. Klingel R, Fassbender C, Fassbender T, Gohlen B. Clinical studies to implement rheopheresis for age-related macular degeneration guided by evidence-based-medicine. Transfus Apher Sci 2003 29 : 71 84.
2. Pulido J, Klingel R, Sanders D, Multicenter Investigation of Rheopheresis for AMD (MIRA1) Study Group Writing Committee. Multicenter prospective randomized double-masked placebo controlled study of rheopheresis to treat dry AMD. Interim analysis. Trans Am Ophthalmol Soc 2002 100 : 85 108.
3. Widder RA, Farvili E, Reis RGJ et al. The treatment of age-related macular degeneration (ARMD) with extracorporeal treatment procedures. A follow-up of four years. Invest Ophthalmol Vis Sci 2002 43 : Abst. 2906.
4. Brunner R, Widder RA, Walter P et al. Influence of membrane differential filtration on the natural course of age-related macular degeneration: a randomized trial. Retina 2000 20 : 483 91.
5. Friedman E. Update of the vascular model of AMD. Br J Ophthalmol 2004 88 : 161 3.
6. Friedman E. A hemodynamic model of the pathogenesis of age-related macular degeneration. Am J Ophthalmol 1997 124 : 677 82.
7. Pulido J, Sanders D, Winters JL, Klingel R. Clinical outcomes and mechanism of action for rheopheresis treatment of age-related macular degeneration (AMD). J Clin Apheresis 2005 20 : 166 7.
8. Brunner R, Widder RA, Borberg H. [Extracorporeal treatment procedures for selected ocular diseases]. Ophthalmologe 1999 96 : 679 82.
9. Luke C, Widder RA, Walter P, Brunner R, Kirchhof B, Borberg H. The effect of membrane differential filtration on the colloid osmotic pressure in patients with age-related macular degeneration: significance to visual function? Ther Apher Dial 2003 7 : 263 8.
10. Seebode D, Scheidt H, Schmid-Schonbein H. A pressure chamber to simulate the microcirculation of compartmental syndromes. Microvasc Res 1994 47 : 388 91.
11. Driessen G, Rutten W, Inhoffen W, Scheidt H, Heidtmann H. Is the laser Doppler flow signal a measure of microcirculatory cell flux? Int J Microcirc Clin Exp 1990 9 : 141 61.
12. Driessen G, Scheidt H, Inhoffen W, Sobota A, Malotta H, Schmid-Schonbein H. A comparative study: perfusion of the micro- and macrocirculation as a function of the hematocrit value. Microvasc Res 1988 35 : 73 85.
13. Driessen G, Scheidt H, Heidtmann H, Inhoffen W, Schmid-Schonbein H. A comparison of micro- and macrocirculation of the isolated rat mesentery preparation. Microcirc Endothelium Lymphatics 1985 2 : 551 74.
14. Driessen GK, Scheidt-Bleichert H, Sobota A et al. Capillary resistance to flow of hardened (diamide treated) red blood cells (RBC). Pflügers Arch 1982 392 : 261 7.
15. Driessen G, Heidtmann H, Scheidt H, Schmid-Schonbein H. Effect of hemodilution and hemoconcentration on microcirculatory perfusion. Bibl Haematol 1981 47 : 21 30.
16. Driessen GK, Haest CW, Heidtmann H, Kamp D, Schmid-Schonbein H. Effect of reduced red cell 'deformability' on flow velocity in capillaries of rat mesentery. Pflügers Arch 1980 388 : 75 8.
17. Driessen GK, Heidtmann H, Schmid-Schonbein H. Effect of hemodilution and hemoconcentration on red cell flow velocity in the capillaries of the rat mesentery. Pflügers Arch 1979 380 : 1 6.
18. Klingel R, Fassbender C, Fischer I et al. Rheopheresis for age-related macular degeneration: a novel indication for therapeutic apheresis in ophthalmology. Ther Apher 2002 6 : 271 81.
19. Brunner R. Hämorheologische Therapie bei Uveitis und Makulopathie. Heidelberg : Kaden Verlag, 1993.
20. Dati F, Schumann G, Thomas L et al. Consensus of a group of professional societies and diagnostic companies on guidelines for interim reference ranges for 14 proteins in serum based on the standardization against the IFCC/BCR/CAP Reference Material (CRM 470). International Federation of Clinical Chemistry. Community Bureau of Reference of the Commission of the European Communities. College of American Pathologists. Eur J Clin Chem Clin Biochem 1996 34 : 517 20.
21. Thomas L. [Laboratory and Diagnosis]. Frankfurt/Main : TH-Books, 2007.
22. Schechner V, Shapira I, Berliner S et al. Significant dominance of fibrinogen over immunoglobulins, C-reactive protein, cholesterol and triglycerides in maintaining increased red blood cell adhesiveness/aggregation in the peripheral venous blood: a model in hypercholesterolaemic patients. Eur J Clin Invest 2003 33 : 955 61.
23. Lominadze D, Dean WL. Involvement of fibrinogen specific binding in erythrocyte aggregation. FEBS Lett 2002 517 : 41 4.
24. Marton Z, Kesmarky G, Vekasi J et al. Red blood cell aggregation measurements in whole blood and in fibrinogen solutions by different methods. Clin Hemorheol Microcirc 2001 24 : 75 83.
25. Berliner S, Rotstein R, Fusman R et al. Increased erythrocyte adhesiveness/aggregation in the peripheral venous blood of patients with ischaemic heart disease and an eventful course. Acta Cardiol 2001 56 : 121 6.
26. Varlet-Marie E, Gaudard A, Monnier JF et al. Reduction of red blood cell disaggregability during submaximal exercise: relationship with fibrinogen levels. Clin Hemorheol Microcirc 2003 28 : 139 49.
27. Ben Ami R, Barshtein G, Mardi T et al. A synergistic effect of albumin and fibrinogen on immunoglobulin-induced red blood cell aggregation. Am J Physiol Heart Circ Physiol 2003 285 : H2663 9.
28. Vaya A, Falco C, Reganon E et al. Influence of plasma and erythrocyte factors on red blood cell aggregation in survivors of acute myocardial infarction. Thromb Haemost 2004 91 : 354 9.
29. Schuff-Werner P. Increased red blood cell adhesiveness/aggregation owing to fibrinogen elevation in hypercholesterolaemic patients and the rationale of fibrinogen-lowering by LDL apheresis. Eur J Clin Invest 2004 34 : 378 9.
30. Pulanic D, Rudan I. The past decade: fibrinogen. Coll Antropol 2005 29 : 341 9.
31. Tamai M, Mizuno K, Chader GJ. In vitro studies on shedding and phagocytosis of rod outer segments in the rat retina: effect of oxygen concentration. Invest Ophthalmol Vis Sci 1982 22 : 439 48.